Idorsia and viatris enter into a significant global research and development collaboration

Ad hoc announcement pursuant to art. 53 lr viatris and idorsia will collaborate on the global development and commercialization of two phase 3 assets, selatogrel and cenerimod.
VTRS Ratings Summary
VTRS Quant Ranking